SCHEMBL5653072

SCHEMBL5653072

CC1CC1CNCc1ccn(C)n1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.49
KDM1A O60341 2/20 0.39
PDCD1 Q15116 2/20 0.36
CD274 Q9NZQ7 2/20 0.36
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
NAMPT P43490 3/20 0.34
PDE7B Q9NP56 2/20 0.33
ROCK2 O75116 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
GLS O94925 1/20 0.32
APOL1 O14791 1/20 0.31
HPGDS O60760 1/20 0.31
KCNH2 Q12809 2/20 0.31
GRIN2B Q13224 1/20 0.31
HTR2C P28335 1/20 0.30
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652881 1.00 EPHX2 (0.49) EPHX2KDM1APDCD1CD274DDB1
SCHEMBL24613090 0.75 EPHX2 (0.64) EPHX2KDM1APDCD1CD274DDB1
SCHEMBL2259759 0.74 EPHX2 (0.58) EPHX2KDM1APDCD1CD274DDB1
SCHEMBL6668265 0.70 KDM1A (0.48) EPHX2KDM1ADDB1CRBNNAMPT
SCHEMBL21290463 0.70 EPHX2 (0.54) EPHX2KDM1APDCD1CD274DDB1
SCHEMBL5648316 0.70 ALDH1A1 (0.45) KDM1ACD274HTR2C
SCHEMBL31055717 0.69 EPHX2 (0.74) EPHX2KDM1APDCD1CD274OPRM1
SCHEMBL5651150 0.69 OPRK1 (0.36) PDE7B
SCHEMBL5651151 0.69 OPRK1 (0.36) PDE7B
SCHEMBL18924762 0.68 EPHX2 (0.51) EPHX2KDM1APDCD1CD274DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394837-B2 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme, Corp. (US) 2013-03-12 US disclosed
US-8394837-B2 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme, Corp. (US) 2013-03-12 US disclosed
EP-1817311-B1 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2012-10-17 EP disclosed
US-20070293497-A1 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease MERCK SHARP & DOHME LLC 2007-12-20 US disclosed
US-20070293497-A1 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease MERCK SHARP & DOHME LLC 2007-12-20 US disclosed
WO-2006057945-A2 2,3,4,6-SUBSTITUTED PYRIDYL DERIVATIVE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2006-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293497-A1 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease BACE1, BACE2, PSEN2 EPHX2 405/4885KDM1A 2579/4885PDCD1 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.